The global tuberculosis situation. Progress and problems in the 20th century, prospects for the 21st century (Q34579146)

3 August 2017

1 reference

title

The global tuberculosis situation. Progress and problems in the 20th century, prospects for the 21st century (English)

1 reference

3 August 2017

0 references

4

Thomas R Frieden

1 reference

3 August 2017

Mario C Raviglione

9

0 references

J Peter Cegielski

1

object named as

J Peter Cegielski

1 reference

3 August 2017

Daniel P Chin

2

1 reference

3 August 2017

Marcos A Espinal

3

1 reference

3 August 2017

Rodolfo Rodriquez Cruz

5

1 reference

3 August 2017

Elizabeth A Talbot

6

1 reference

3 August 2017

Diana E C Weil

7

1 reference

3 August 2017

Richard Zaleskis

8

1 reference

3 August 2017

1 March 2002

1 reference

Infectious Disease Clinics of North America

3 August 2017

1 reference

3 August 2017

16

1 reference

3 August 2017

1

1 reference

3 August 2017

1-58

1 reference

A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA)

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Comparative genomics of BCG vaccines by whole-genome DNA microarray

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

The role of fluoroquinolones in tuberculosis today

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

The intrinsic transmission dynamics of tuberculosis epidemics

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Control strategies for tuberculosis epidemics: new models for old problems

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Drug-resistant tuberculosis in northern Germany: a retrospective hospital-based study of 1,055 patients from 1984 until 1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Quantitative bacillary response to treatment in HIV-associated pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

National trends in the concurrence of tuberculosis and acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Tuberculous pericarditis in Tanzanian patients with and without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Unusual pulmonary manifestations of disseminated Penicillium marneffei infection in three AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Streptomycin resistance in pulmonary tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Pulmonary complications of HIV infection in Dar es Salaam, Tanzania. Role of bronchoscopy and bronchoalveolar lavage

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Critical assessment of smear-positive pulmonary tuberculosis patients after chemotherapy under the district tuberculosis programme.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Tuberculosis and HIV infection in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Mycobacterium tuberculosis in the post-genomic age.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Tuberculosis in Siberia: 2. Diagnosis, chemoprophylaxis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Tuberculosis in Siberia: 1. An epidemiological and microbiological assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Evaluating the impact of tuberculosis control: number of deaths prevented by short-course chemotherapy in China

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

The impact of HIV on infectiousness of pulmonary tuberculosis: a community study in Zambia.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Review: the immune response in human tuberculosis--implications for tuberculosis control

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Infectiousness of Mycobacterium tuberculosis in HIV-1-infected patients with tuberculosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus".

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Tuberculosis in New York City--turning the tide

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Clinical consequences and transmissibility of drug-resistant tuberculosis in southern Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Recruitment to a trial of tuberculosis preventive therapy from a voluntary HIV testing centre in Lusaka: relevance to implementation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Rhodococcus equi and HIV-1 infection in Uganda.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

A prospective study of the risk of tuberculosis among HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

PUBLIC HEALTH: Responding to Market Failures in Tuberculosis Control

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Detection of Mycobacterium tuberculosis by molecular methods.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

A prospective evaluation of antituberculosis therapy in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Two-year follow-up of persons with HIV-1- and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

The nature and consequence of genetic variability within Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

CD4 T lymphocyte count and the radiographic presentation of pulmonary tuberculosis. A study of the relationship between these factors in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Immigration and tuberculosis among children on the United States-Mexico border, County of San Diego, California

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Use of mycobacterial smears in the diagnosis of pulmonary tuberculosis in AIDS/ARC patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Molecular and conventional epidemiology of Mycobacterium tuberculosis in Botswana: a population-based prospective study of 301 pulmonary tuberculosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

The impact of HIV on the usefulness of sputum smears for the diagnosis of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Incidence of tuberculosis in the United States among HIV-infected persons. The Pulmonary Complications of HIV Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Delayed-type hypersensitivity testing in Tanzanian adults with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Risk for Developing Tuberculosis among Anergic Patients Infected with HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Radiologic features of Rhodococcus equi pneumonia in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Twice weekly tuberculosis preventive therapy in HIV infection in Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Randomised trial of thiacetazone and rifampicin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans. The Makerere University-Case Western University Research Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG).

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

AIDS in Africa: an epidemiologic paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Tuberculosis trends in eastern Europe and the former USSR.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Overview and epidemiologic assessment of the current global tuberculosis situation with an emphasis on control in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Tuberculosis among European patients with the acquired immune deficiency syndrome. The AIDS in Europe Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

The proportion of tuberculosis cases in Tanzania attributable to human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Directly observed therapy and treatment adherence

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

A study of tuberculosis among foreign-born Hispanic persons in the U.S. States bordering Mexico

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in rural Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Rapid increase in HIV-related tuberculosis, Chiang Rai, Thailand, 1990-1994

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Trend of initial drug resistance of tubercle bacilli isolated from new patients with pulmonary tuberculosis and its correlation with the tuberculosis programme in Beijing

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2803%2900045-X

7 January 2021

10.1016/S0891-5520(03)00045-X

Identifiers

DOI

1 reference

3 August 2017

1 reference